Pragmatic Trials across the Cancer Control Continuum (UG3/UH3 Clinical Trial Required)
Key Information
Due Date: November 17, 2025
Agency: U.S. Department of Health and Human Services (HHS)
Source: Federal
Funding Category:
Health & Human Services
Funding Amount: $581,371
Funding Type: Cooperative Agreement
Match Required: No
Status: Posted
Contact Info:
grantsinfo@nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Overview
This funding opportunity specifically supports research examining the impact of cancer interventions on cancer-related outcomes across all stages of cancer control. The research approach should utilize a pragmatic trial study design, which is a practical, real-world testing technique.
Funding for this project is set up through a two-step cooperative agreement mechanism labeled UG3/UH3. The UG3 phase is designed to fine-tune the cancer-related intervention and conclude all study-related tasks in readiness for the UH3 phase. The subsequent UH3 phase is intended for actual implementation of the pragmatic trial.
Key Dates
Open Date: November 23, 2022
Application Due Date: November 17, 2025
Estimated Award Date: Not Specified
Additional Details
Eligible Activities
- Research and Development
Eligible Applicants
- State governments
- County governments
- City, village or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Private institutions of higher education
- Small businesses